OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
November 28, 2017
From pressurized metered dose inhalers to connected breath-actuated inhaler platforms and dry powder inhalers, Aptar Pharma’s c-Device solutions are developed to meet the unique data stream objectives of its customers
October 24, 2017
September 19, 2017
Aptar Pharma’s Unit-Dose Systems (UDS) are the preferred drug delivery technology spray platforms when dose accuracy and ease of administration are critical in a single nasal for liquid or powder drug delivery.
June 13, 2017
Aptar Pharma’s e-Lockout device is the first and only fully integrated electronic nasal drug delivery device to be approved by a US or European regulatory authority.
May 16, 2017
Aptar Pharma and Kali Care have announced that they entered into a partnership in order to address the challenge of monitoring adherence in ophthalmic clinical trials.
March 14, 2017